(Q24793430)

2 July 2017

title

International variation in prescribing antihypertensive drugs: its extent and possible explanations (English)

1 reference

2 July 2017

2

Andrew D Oxman

1 reference

2 July 2017

1

Atle Fretheim

1 reference

2 July 2017

language of work or name

English

0 references

publication date

11 March 2005

1 reference

BMC Health Services Research

2 July 2017

published in

1 reference

2 July 2017

volume

5

1 reference

2 July 2017

issue

1

1 reference

2 July 2017

page(s)

21

1 reference

The potential savings of using thiazides as the first choice antihypertensive drug: cost-minimisation analysis

2 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1079831

Therapeutic-class wars--drug promotion in a competitive marketplace

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1079831

Variations and increase in use of statins across Europe: data from administrative databases

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1079831

A qualitative study to explore influences on general practitioners' decisions to prescribe new drugs

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1079831

Changing provider behavior: an overview of systematic reviews of interventions.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1079831

Do drug company promotions influence physician behavior?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1079831

The effect of fundholding on prescribing and referral costs: a review of the evidence.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1079831

Marketing aspects of company-sponsored postmarketing surveillance studies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1079831

Impact of clinical trial results on national trends in alpha-blocker prescribing, 1996-2002.

28 September 2017

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1472-6963-5-21

Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15762983

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effect of antihypertensive samples on physician prescribing patterns

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15762983

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Influences of educational interventions and adverse news about calcium-channel blockers on first-line prescribing of antihypertensive drugs to elderly people in British Columbia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15762983

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1472-6963-5-21

1 reference

Dimensions Publication ID

2 July 2017

1018296433

0 references

OpenCitations bibliographic resource ID

2386161

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2386161

1 reference